Cardinal Health, Inc. $CAH Stock Holdings Lifted by Artemis Investment Management LLP

Artemis Investment Management LLP raised its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 17.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 344,230 shares of the company's stock after purchasing an additional 50,458 shares during the quarter. Artemis Investment Management LLP owned approximately 0.14% of Cardinal Health worth $70,739,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Vanguard Group Inc. lifted its position in shares of Cardinal Health by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company's stock worth $6,461,179,000 after buying an additional 617,775 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company's stock worth $911,010,000 after buying an additional 3,511,579 shares during the last quarter. Bank of America Corp DE lifted its position in shares of Cardinal Health by 3.2% in the third quarter. Bank of America Corp DE now owns 3,592,775 shares of the company's stock worth $563,922,000 after buying an additional 111,582 shares during the last quarter. Invesco Ltd. lifted its position in shares of Cardinal Health by 14.7% during the 3rd quarter. Invesco Ltd. now owns 3,483,207 shares of the company's stock worth $546,724,000 after purchasing an additional 445,425 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its position in shares of Cardinal Health by 44.9% during the 3rd quarter. Victory Capital Management Inc. now owns 2,284,115 shares of the company's stock worth $352,165,000 after purchasing an additional 707,495 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Trending Headlines about Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Q3 non‑GAAP earnings beat estimates and company raised FY‑2026 guidance to $10.70–$10.80, above consensus — the core bullish catalyst. PR Newswire: Q3 Results & Outlook
• Positive Sentiment: Company executed $250M additional share repurchase (bringing FY26 repurchases to $1.0B) and reduced debt — shareholder‑friendly actions that support the share price. PR Newswire: Buybacks & Debt Reduction
• Neutral Sentiment: Wells Fargo cut its price target from $256 to $245 but kept an "overweight" rating, signaling continued analyst confidence despite the trim. Benzinga: Wells Fargo PT Change
• Neutral Sentiment: Full earnings call and transcripts are available for investors who want details on segment performance and management commentary. Yahoo Finance: Earnings Transcript Seeking Alpha: Call Transcript
• Negative Sentiment: Revenue missed expectations ($60.9B reported vs. ~$62.1B est.), which prompted media coverage and short‑term selling pressure despite the EPS beat. Benzinga: Revenue Miss Coverage
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and GAAP EPS declined, driven in part by a $184M pre‑tax goodwill impairment in the Navista & ION reporting unit — a one‑time charge that reduces headline profitability. PR Newswire: Goodwill Impairment
• Negative Sentiment: Several outlets highlighted the "mixed" nature of the report (EPS/guidance vs. revenue/GAAP weakness), which can increase volatility and keep some investors on the sidelines. CNBC: Mixed Results Coverage

Cardinal Health Price Performance

NYSE CAH opened at $195.13 on Friday. The firm has a market cap of $45.92 billion, a PE ratio of 28.08, a price-to-earnings-growth ratio of 1.19 and a beta of 0.53. Cardinal Health, Inc. has a one year low of $137.75 and a one year high of $233.60. The stock's 50 day simple moving average is $213.73 and its 200 day simple moving average is $205.46.

Cardinal Health (NYSE:CAH - Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts' consensus estimates of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.Cardinal Health's revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the prior year, the company earned $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, equities analysts expect that Cardinal Health, Inc. will post 10.79 earnings per share for the current year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Shareholders of record on Wednesday, April 1st were given a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date was Wednesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 29.35%.

Wall Street Analyst Weigh In

CAH has been the subject of several research analyst reports. William Blair initiated coverage on Cardinal Health in a research report on Tuesday. They set an "outperform" rating for the company. Jefferies Financial Group boosted their price objective on Cardinal Health from $220.00 to $270.00 and gave the stock a "buy" rating in a research report on Thursday, January 22nd. Leerink Partners reissued an "outperform" rating and set a $275.00 price objective on shares of Cardinal Health in a research report on Monday, March 9th. Evercore cut their price objective on Cardinal Health from $260.00 to $240.00 and set an "outperform" rating for the company in a research report on Wednesday, April 8th. Finally, Zacks Research raised Cardinal Health from a "hold" rating to a "strong-buy" rating in a research report on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $243.67.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.